Kevin Caliendo
Stock Analyst at UBS
(4.81)
# 107
Out of 4,667 analysts
159
Total ratings
88%
Success rate
20.63%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintains: Neutral | $60 → $62 | $56.83 | +9.10% | 6 | Nov 7, 2024 | |
| COR Cencora | Maintains: Buy | $275 → $285 | $243.20 | +17.19% | 1 | Nov 7, 2024 | |
| OMI Owens & Minor | Maintains: Buy | $28 → $25 | $11.89 | +110.26% | 4 | Nov 5, 2024 | |
| CAH Cardinal Health | Maintains: Buy | $134 → $139 | $119.77 | +16.06% | 15 | Nov 4, 2024 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $9 → $12 | $11.95 | +0.42% | 6 | Oct 30, 2024 | |
| DGX Quest Diagnostics | Maintains: Neutral | $165 → $166 | $161.03 | +3.09% | 12 | Oct 23, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Neutral | $9 → $10 | $8.24 | +21.36% | 14 | Oct 17, 2024 | |
| UNH UnitedHealth Group | Maintains: Buy | $680 → $650 | $599.03 | +8.51% | 11 | Oct 16, 2024 | |
| HUM Humana | Maintains: Neutral | $380 → $250 | $293.39 | -14.79% | 6 | Oct 4, 2024 | |
| LFST LifeStance Health Group | Maintains: Neutral | $9 → $7.5 | $7.22 | +3.88% | 3 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $8.5 | $4.31 | +97.22% | 3 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $75 → $72 | $73.73 | -2.35% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $260 → $270 | $236.79 | +14.03% | 1 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $12 | $7.84 | +53.06% | 2 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $620 → $630 | $621.47 | +1.37% | 13 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $280 → $320 | $223.87 | +42.94% | 17 | Apr 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $385 → $400 | $322.69 | +23.96% | 10 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $26 | $20.37 | +27.64% | 1 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $350 → $380 | $290.73 | +30.71% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $59.10 | +33.67% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $46 | $11.31 | +306.72% | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $29 → $26 | $22.23 | +16.96% | 1 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $399.15 | +44.06% | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $153.87 | +16.98% | 7 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $58 → $47 | $18.52 | +153.78% | 8 | Jun 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $9.10 | +691.64% | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $17.05 | -35.48% | 4 | May 4, 2021 |
CVS Health
Nov 7, 2024
Maintains: Neutral
Price Target: $60 → $62
Current: $56.83
Upside: +9.10%
Cencora
Nov 7, 2024
Maintains: Buy
Price Target: $275 → $285
Current: $243.20
Upside: +17.19%
Owens & Minor
Nov 5, 2024
Maintains: Buy
Price Target: $28 → $25
Current: $11.89
Upside: +110.26%
Cardinal Health
Nov 4, 2024
Maintains: Buy
Price Target: $134 → $139
Current: $119.77
Upside: +16.06%
Alignment Healthcare
Oct 30, 2024
Maintains: Neutral
Price Target: $9 → $12
Current: $11.95
Upside: +0.42%
Quest Diagnostics
Oct 23, 2024
Maintains: Neutral
Price Target: $165 → $166
Current: $161.03
Upside: +3.09%
Walgreens Boots Alliance
Oct 17, 2024
Maintains: Neutral
Price Target: $9 → $10
Current: $8.24
Upside: +21.36%
UnitedHealth Group
Oct 16, 2024
Maintains: Buy
Price Target: $680 → $650
Current: $599.03
Upside: +8.51%
Humana
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $293.39
Upside: -14.79%
LifeStance Health Group
Aug 15, 2024
Maintains: Neutral
Price Target: $9 → $7.5
Current: $7.22
Upside: +3.88%
Aug 9, 2024
Maintains: Neutral
Price Target: $9 → $8.5
Current: $4.31
Upside: +97.22%
Aug 7, 2024
Maintains: Neutral
Price Target: $75 → $72
Current: $73.73
Upside: -2.35%
Aug 2, 2024
Maintains: Buy
Price Target: $260 → $270
Current: $236.79
Upside: +14.03%
May 23, 2024
Maintains: Neutral
Price Target: $30 → $12
Current: $7.84
Upside: +53.06%
May 8, 2024
Maintains: Buy
Price Target: $620 → $630
Current: $621.47
Upside: +1.37%
Apr 15, 2024
Maintains: Neutral
Price Target: $280 → $320
Current: $223.87
Upside: +42.94%
Mar 8, 2024
Maintains: Buy
Price Target: $385 → $400
Current: $322.69
Upside: +23.96%
Jan 5, 2024
Initiates: Neutral
Price Target: $26
Current: $20.37
Upside: +27.64%
Dec 21, 2023
Maintains: Neutral
Price Target: $350 → $380
Current: $290.73
Upside: +30.71%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $59.10
Upside: +33.67%
Oct 16, 2023
Initiates: Buy
Price Target: $46
Current: $11.31
Upside: +306.72%
Aug 23, 2023
Maintains: Neutral
Price Target: $29 → $26
Current: $22.23
Upside: +16.96%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $399.15
Upside: +44.06%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $153.87
Upside: +16.98%
Jun 2, 2022
Upgrades: Buy
Price Target: $58 → $47
Current: $18.52
Upside: +153.78%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $9.10
Upside: +691.64%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $17.05
Upside: -35.48%